题名

Tetrabenazine for Treating Neuroleptic-induced Tardive Dyskinesia: A Case Report of a Patient with Chronic Schizophrenia

DOI

10.4103/TPSY.TPSY_40_21

作者

Pao-Yuan Ching；Chih-Chuan Pan；Cheng-Ho Chang

关键词
期刊名称

台灣精神醫學

卷期/出版年月

35卷4期（2021 / 12 / 01）

页次

208 - 209

内容语文

英文
主题分类 醫藥衛生 > 社會醫學
参考文献
  1. Liou, CP,Fang, CK,Hsu, SC(2006).Flupentixol decanoate-related tardive dyskinesia.Taiwanese J Psychiatry,20,230-239.
    連結：
  2. Caroff, SN,Aggarwal, S,Yonan, C(2018).Treatment of tardive dyskinesia with tetrabenazine or valbenazine: a systematic review.J Comp Eff Res,7,135-148.
  3. Eiden, LE,Weihe, E(2011).VMAT2: A dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.Ann N Y Acad Sci,1216,86-98.
  4. Guy, W(ed.)(1976).ECDEU Assessment Manual for Psychopharmacology.Rockville, Maryland, USA:National Institute of Mental Health.
  5. Kaur, N,Kumar, P,Jamwal, S(2016).Tetrabenazine: Spotlight on drug review.Ann Neurosci,23,176-185.
  6. Mejia, NI,Jankovic, J(2010).Tardive dyskinesia and withdrawal emergent syndrome in children.Expert Rev Neurother,10,893-901.
  7. Ondo, WG,Hanna, PA(1999).Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol.Am J Psychiatry,156,1279-1281.
  8. Solmi, M,Pigato, G,Kane, JM(2018).Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials.Drug Des Devel Ther,12,1215-1238.
  9. Waln, O,Jankovic, J(2013).An update on tardive dyskinesia: from phenomenology to treatment.Tremor Other Hyperkinet,3(tre-03-161-4138-1)
print cancel